Cargando…
Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma
BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differen...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797838/ https://www.ncbi.nlm.nih.gov/pubmed/35116596 http://dx.doi.org/10.21037/tcr-20-2275 |
_version_ | 1784641650357698560 |
---|---|
author | Liu, Libao Xu, Shilei Huang, Lei He, Jinyuan Liu, Gang Ma, Shaohong Weng, Yimin Huang, Shaohong |
author_facet | Liu, Libao Xu, Shilei Huang, Lei He, Jinyuan Liu, Gang Ma, Shaohong Weng, Yimin Huang, Shaohong |
author_sort | Liu, Libao |
collection | PubMed |
description | BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differential expression genes (DEGs) were identified by ESTIMATE algorithm and linear models for microarray analyses (LIMMA), respectively. CIBERSORT and Igraph algorithms were applied to construct the LUAD-related immunocyte infiltration and regulatory network. Kaplan-Meier survival analysis, and univariate and multivariate Cox analysis were used to predict independent risk factors and screen for the hub genes. In addition, hub genes-correlated gene set enrichment analysis (GSEA), tumor mutation burden (TMB), and clinic pathological relation analyses were also performed. RESULTS: Stromal, immune, and microenvironment comprehensive features (ESTIMATE score) were associated with overall survival (OS) in LUAD patients (all, P<0.05). T-cell activation, chemokine activity, and immune effect or dysfunction gene ontology maps were associated with the LUAD immune microenvironment. The immune infiltration cell subtypes mast cells (masT-cells) resting [The Cancer Genome Atlas (TCGA): P=0.01; Gene Expression Omnibus (GEO): P=1.79e−05] and activated T-cells (CD4 memory) (TCGA: P<0.01; GEO: P=8.52e−05) were found to have an important role in the immune cell regulatory network. Finally, ITGAL [univariate hazard ratio (HR) =0.80, 95% confidence interval (CI): 0.69–0.93, P<0.01; multivariate HR =0.59, 95% CI: 0.40–0.86, P=0.01] and KLRB1 (univariate HR =0.78, 95% CI: 0.69–0.89, P<0.01; multivariate HR =0.72, 95% CI: 0.58–0.90, P<0.01) were correlated with the T-cell receptor signaling pathway and anaplastic lymphoma kinase (ALK) fusion (ITGAL: P=0.034; KLRB1: P=0.050), and were considered as candidate biomarkers. A significant relation between KLRB1 expression level and TMB (P=3.6e−05) was identified, while no relation was detected for ITGAL (P=0.11). CONCLUSIONS: The T-cell activation and activated T-cell (CD4 memory) pathways were predominantly involved in LUAD immune microenvironment regulation. The expression levels of ITGAL and KLRB1 were significantly correlated with the T-cell receptor signaling pathway and LUAD TMB, and were independent risk factors for OS. |
format | Online Article Text |
id | pubmed-8797838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87978382022-02-02 Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma Liu, Libao Xu, Shilei Huang, Lei He, Jinyuan Liu, Gang Ma, Shaohong Weng, Yimin Huang, Shaohong Transl Cancer Res Original Article BACKGROUND: This study applied a complex bioinformatics analysis to explore the hub regulators and immune network to further elucidate the molecular mechanisms of lung adenocarcinoma (LUAD) immune regulation. METHODS: LUAD immunological microenvironment features and microenvironment-related differential expression genes (DEGs) were identified by ESTIMATE algorithm and linear models for microarray analyses (LIMMA), respectively. CIBERSORT and Igraph algorithms were applied to construct the LUAD-related immunocyte infiltration and regulatory network. Kaplan-Meier survival analysis, and univariate and multivariate Cox analysis were used to predict independent risk factors and screen for the hub genes. In addition, hub genes-correlated gene set enrichment analysis (GSEA), tumor mutation burden (TMB), and clinic pathological relation analyses were also performed. RESULTS: Stromal, immune, and microenvironment comprehensive features (ESTIMATE score) were associated with overall survival (OS) in LUAD patients (all, P<0.05). T-cell activation, chemokine activity, and immune effect or dysfunction gene ontology maps were associated with the LUAD immune microenvironment. The immune infiltration cell subtypes mast cells (masT-cells) resting [The Cancer Genome Atlas (TCGA): P=0.01; Gene Expression Omnibus (GEO): P=1.79e−05] and activated T-cells (CD4 memory) (TCGA: P<0.01; GEO: P=8.52e−05) were found to have an important role in the immune cell regulatory network. Finally, ITGAL [univariate hazard ratio (HR) =0.80, 95% confidence interval (CI): 0.69–0.93, P<0.01; multivariate HR =0.59, 95% CI: 0.40–0.86, P=0.01] and KLRB1 (univariate HR =0.78, 95% CI: 0.69–0.89, P<0.01; multivariate HR =0.72, 95% CI: 0.58–0.90, P<0.01) were correlated with the T-cell receptor signaling pathway and anaplastic lymphoma kinase (ALK) fusion (ITGAL: P=0.034; KLRB1: P=0.050), and were considered as candidate biomarkers. A significant relation between KLRB1 expression level and TMB (P=3.6e−05) was identified, while no relation was detected for ITGAL (P=0.11). CONCLUSIONS: The T-cell activation and activated T-cell (CD4 memory) pathways were predominantly involved in LUAD immune microenvironment regulation. The expression levels of ITGAL and KLRB1 were significantly correlated with the T-cell receptor signaling pathway and LUAD TMB, and were independent risk factors for OS. AME Publishing Company 2021-06 /pmc/articles/PMC8797838/ /pubmed/35116596 http://dx.doi.org/10.21037/tcr-20-2275 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Original Article Liu, Libao Xu, Shilei Huang, Lei He, Jinyuan Liu, Gang Ma, Shaohong Weng, Yimin Huang, Shaohong Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title | Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title_full | Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title_fullStr | Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title_full_unstemmed | Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title_short | Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
title_sort | systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797838/ https://www.ncbi.nlm.nih.gov/pubmed/35116596 http://dx.doi.org/10.21037/tcr-20-2275 |
work_keys_str_mv | AT liulibao systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT xushilei systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT huanglei systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT hejinyuan systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT liugang systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT mashaohong systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT wengyimin systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma AT huangshaohong systemicimmunemicroenvironmentandregulatorynetworkanalysisinpatientswithlungadenocarcinoma |